ArticleCancer control : journal of the Moffitt Cancer Center

Cost-effectiveness of FOLFOX6+Bevacizumab Versus FOLFOX6+Cetuximab in Stage IV Colorectal Cancer Patients in Shiraz, Iran.

Abdosaleh Jafari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.